Abbott Laboratories (ABT) operating KPIs
ABTNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 28, 2026Score 14/3036% above fair value
$106.20+1.63 (+1.56%)
Close on Oct 30, 2026Market cap $183.77BP/E 34.1Yield 2.26%
Abbott Laboratories geographic Revenue — United States ($M) ($M)
Postgres DB segment_values + Form 10-K Segment & Geographic Footnote
Latest, Q2 2026
5,216
Period ended Jun 30, 2026
Change on a year earlier
+22.0%
4,276 in Q2 2025
History
38 quarters
Since Q1 2017
Sources
34
Documents cited below
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Geographic Revenue — United States ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q2 2026 | Jun 30, 2026 | 5,216 | +22.0% | Form 10-Q (filed 2026-07-28) ↗ |
| Q1 2026 | Mar 31, 2026 | 4,274 | +2.5% | Form 10-Q (filed 2026-04-29) ↗ |
| Q4 2025 | Dec 31, 2025 | 4,383 | +1.0% | Form 10-K (filed 2026-02-20) ↗ |
| Q3 2025 | Sep 30, 2025 | 4,299 | +2.3% | Form 10-Q (filed 2025-10-29) ↗ |
| Q2 2025 | Jun 30, 2025 | 4,276 | +8.7% | Form 10-Q (filed 2025-07-30) ↗ |
| Q1 2025 | Mar 31, 2025 | 4,168 | +8.4% | Form 10-Q (filed 2025-04-30) ↗ |
| Q4 2024 | Dec 31, 2024 | 4,341 | +9.9% | Form 10-K (filed 2025-02-21) ↗ |
| Q3 2024 | Sep 30, 2024 | 4,202 | +10.1% | Form 10-Q (filed 2024-10-31) ↗ |
| Q2 2024 | Jun 30, 2024 | 3,934 | +4.7% | Form 10-Q (filed 2024-07-31) ↗ |
| Q1 2024 | Mar 31, 2024 | 3,846 | -2.1% | Form 10-Q (filed 2024-05-02) ↗ |
| Q4 2023 | Dec 31, 2023 | 3,949 | -6.4% | Form 10-K (filed 2024-02-16) ↗ |
| Q3 2023 | Sep 30, 2023 | 3,817 | -6.8% | Form 10-Q (filed 2023-11-01) ↗ |
| Q2 2023 | Jun 30, 2023 | 3,758 | -23.2% | Form 10-Q (filed 2023-08-03) ↗ |
| Q1 2023 | Mar 31, 2023 | 3,928 | -20.4% | Form 10-Q (filed 2023-05-04) ↗ |
| Q4 2022 | Dec 31, 2022 | 4,219 | -13.1% | Form 10-K (filed 2023-02-17) ↗ |
| Q3 2022 | Sep 30, 2022 | 4,094 | -6.3% | Form 10-Q (filed 2022-11-01) ↗ |
| Q2 2022 | Jun 30, 2022 | 4,892 | +36.6% | Form 10-Q (filed 2022-08-02) ↗ |
| Q1 2022 | Mar 31, 2022 | 4,937 | +28.6% | Form 10-Q (filed 2022-05-03) ↗ |
| Q4 2021 | Dec 31, 2021 | 4,855 | +15.6% | Form 10-K (filed 2022-02-18) ↗ |
| Q3 2021 | Sep 30, 2021 | 4,368 | +31.2% | Form 10-Q (filed 2021-11-03) ↗ |
| Q2 2021 | Jun 30, 2021 | 3,581 | +35.7% | Form 10-Q (filed 2021-08-04) ↗ |
| Q1 2021 | Mar 31, 2021 | 3,838 | +34.4% | Form 10-Q (filed 2021-05-05) ↗ |
| Q4 2020 | Dec 31, 2020 | 4,199 | +41.9% | Form 10-K (filed 2021-02-19) ↗ |
| Q3 2020 | Sep 30, 2020 | 3,329 | +17.5% | Form 10-Q (filed 2020-11-04) ↗ |
| Q2 2020 | Jun 30, 2020 | 2,638 | -7.4% | Form 10-Q (filed 2020-07-29) ↗ |
| Q1 2020 | Mar 31, 2020 | 2,856 | +3.7% | Form 10-Q (filed 2020-04-29) ↗ |
| Q4 2019 | Dec 31, 2019 | 2,960 | +7.4% | Form 10-K (filed 2020-02-21) ↗ |
| Q3 2019 | Sep 30, 2019 | 2,834 | +4.7% | Form 10-Q (filed 2019-10-31) ↗ |
| Q2 2019 | Jun 30, 2019 | 2,850 | +5.5% | Form 10-Q (filed 2019-07-31) ↗ |
| Q1 2019 | Mar 31, 2019 | 2,754 | +3.0% | Form 10-Q (filed 2019-05-01) ↗ |
| Q4 2018 | Dec 31, 2018 | 2,755 | +3.0% | Form 10-K (filed 2019-02-22) ↗ |
| Q3 2018 | Sep 30, 2018 | 2,707 | +17.0% | Form 10-Q (filed 2018-10-31) ↗ |
| Q2 2018 | Jun 30, 2018 | 2,702 | +14.5% | Form 10-Q (filed 2018-08-01) ↗ |
| Q1 2018 | Mar 31, 2018 | 2,675 | +15.1% | Form 10-Q (filed 2018-05-02) ↗ |
| Q4 2017 | Dec 31, 2017 | 2,676 | – | Form 10-Q (filed 2018-10-31) ↗ |
| Q3 2017 | Sep 30, 2017 | 2,313 | – | Form 10-Q (filed 2018-10-31) ↗ |
| Q2 2017 | Jun 30, 2017 | 2,360 | – | Form 10-Q (filed 2018-08-01) ↗ |
| Q1 2017 | Mar 31, 2017 | 2,324 | – | Form 10-Q (filed 2018-05-02) ↗ |
Breakdown
What makes up geographic revenue — united states ($m)
- Geographic Revenue — Germany ($M)–
- Geographic Revenue — China ($M)–
- Geographic Revenue — Japan ($M)–
- Geographic Revenue — India ($M)–
- Geographic Revenue — Switzerland ($M)–
- Geographic Revenue — Netherlands ($M)–
- Geographic Revenue — All Other Countries ($M)–
- Long-Lived Assets — United States ($M)11,900 · Q4 2025
- Long-Lived Assets — International ($M)0 · Q4 2025
Cite this data
StockData. (2026). Abbott Laboratories Geographic Revenue — United States ($M) ($M), quarterly Q1 2017–Q2 2026 [Data set]. Compiled from Abbott Laboratories SEC filings and investor materials. https://stockdatahq.com/stocks/abt/kpis/db-geo-us
See every metric in the Abbott Laboratories KPI table. Data updated Oct 29, 2026.